Drugs / Zhigancao Tang granule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04317339 | Mar 2020 → Mar 2022 | diastolic heart failure | Shanghai University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zhigancao Tang granule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04317339 ↗ |
| Known as | Zhigancao Tang granules | “The results of this trial will demonstrate whether Zhigancao Tang granules are effective and safe for treating HFpEF.” PMID 33879223 ↗ Apr 2021 |
| Modality | Traditional medicine (herbal / TCM) | “Zhigancao Tang has been used traditionally for the treatment of cardiovascular diseases in China. The use of traditional Chinese medicine (TCM) is associated with improvements...” PMID 33879223 ↗ Apr 2021 |
| Route | Oral | “twice a day,12 weeks, oral.” NCT04317339 ↗ |